<?xml version="1.0" encoding="UTF-8"?>
<p>Withaferin A exhibited 
 <italic>in vivo</italic> anti-angiogenic activity by inhibiting the transcription factors for vascular endothelial cell growth at very low concentrations (
 <xref rid="B191" ref-type="bibr">191</xref>). Withaferin A, physagulin D, 4-(1-hydroxy-2, 2-dimethylcyclpropanone) 2,3-dihydrowithaferin A, sitoindoside IX, physagulin D (1→6)-β--glucopyranosyl-(1→4)-β -glucopyranoside, 2,3-dihydrowithaferin A, 24,25-dihydro-27-desoxywithaferin A, 27-
 <italic>O</italic>-β--glucopyranosylphysagulin D, 27-
 <italic>O</italic>-β--glucopyranosylviscosalactone B, 4,16-dihydroxy-5β, 6β-epoxyphysagulin D, withanoside IV, and viscosalactone B isolated from alcoholic leaf extract were assessed for antiproliferative activity on NCI-H460 (lungs), HCT-116 (colon), MCF-7 (breast), and SF-268 (central nervous system) human cell lines. Withaferin A with its derivatives viscosalactone B, and 27-
 <italic>O</italic>-glucoside derivatives exhibited significant antiproliferative activity and the IC
 <sub>50</sub> values ranged from 0.01–11.6, 0.05–0.47, and 2.9–17.3 μg/ml, respectively (
 <xref rid="B80" ref-type="bibr">80</xref>). The pretreatment of Wistar rats before exposure to UV radiations with withanolide, 1-oxo-5
 <italic>β</italic>, 6
 <italic>β</italic>-epoxy-witha-2-enolide (20 mg/kg) isolated from the roots of the plant prevented the reoccurrence of skin cancer (
 <xref rid="B192" ref-type="bibr">192</xref>). 
</p>
